---
ProjectName: AIMS-2-TRIALS (Autism Innovative Medicine Studies-2-Trials)
duration: 7
StartYear: 2018
EndYear: 2025
Partners: 
Scope: Biological research on autism treatment and medications
Website: https://www.aims-2-trials.eu/
FundingAgency: Horizon2020
LeadResearcher: Declan Murphy
LeadInstitution: KingColLondon
dg-publish: true
---
